Perceptive Advisors LLC Fully Exits Position in Aldeyra Therapeutics, Inc. (ALDX)

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed Amendment No. 16 to their Schedule 13G regarding Aldeyra Therapeutics, Inc. (ALDX). The filing, dated May 15, 2026, reports that as of the event date on March 31, 2026, the reporting persons have fully exited their position in the company's common stock. The reporting persons now collectively hold 0 shares, representing a 0.0% ownership stake in Aldeyra Therapeutics. This marks a complete liquidation of their previous holdings. Joseph Edelman serves as the Managing Member of Perceptive Advisors LLC and the Master Fund, exercising control over the investment decisions. The filing was made under Rule 13d-1(c), certifying that the securities were not held for the purpose of influencing or changing the control of the issuer. The principal business office for the filers is located in New York, NY.